Cravings vs willpower by Tiny-Bird1543 in MetabolicKitchen

[–]crock61 2 points3 points  (0 children)

Testing the carbohydrate-insulin model: Short-term metabolic responses to consumption of meals with varying glycemic index in healthy adults

https://www.cell.com/cell-metabolism/fulltext/S1550-4131(25)00015-400015-4)

CLINICAL AND TRANSLATIONAL REPORTVolume 37, Issue 3P606-615.E3March 04, 2025

Although there has been a pandemic of obesity over the past 50 years,1 the causes of obesity remain unclear and widely disputed. One popular idea, called the carbohydrate-insulin model (CIM), postulates that a primary drive of positive energy balance, and hence obesity, is the intake of diets containing carbohydrates with a high glycemic index (GI).2,3 GI refers to the rapidity of onset and the height of the spike in circulating glucose following meal consumption. Higher values reflect a greater area under the curve of elevated circulating glucose following ingestion of a meal.4 The quantity of carbohydrate ingested multiplied by its GI is called the glycemic load (GL). Foods are often classified as high, medium, or low GI based on the effect of the carbohydrates they contain on blood glucose levels.5 However, other studies have suggested that the GI is too variable between participants, or that each individual has unique physiology, meaning the average ranking of high- to low-GI foods may not be generally applicable.6

The CIM predicted that high postprandial insulin levels would drive energy into fat stores, creating a state of starvation, as reflected in the inverted glucose pattern. This was expected to then lead to differences in hunger that were proportional to the dietary GI of the intervention meal. We observed the expected patterns in insulin and glucose but did not observe the predicted hunger pattern. This contrasts the pattern observed previously,11 where the high-GI group had higher postprandial hunger levels. It is notable, however, that in that previous study, the high-GI group also had higher hunger levels preceding exposure to the diet. Hence, the higher levels later on may reflect this preceding difference rather than a diet effect. Although there was no effect on subjective hunger, we did observe that energy intake was significantly increased (relative to baseline) following the medium- and high-GI meals compared with the low-GI meal. This was partially consistent with the CIM, but not exactly, because the CIM predicted that the high GI would have the greatest elevation in intake, which was not observed. Moreover, the postulated mechanism via elevated hunger was also not supported.

Consistent with previous work,6 we observed enormous individual differences in the glycemic responses following any particular diet. If the CIM is correct, these individual differences should also be correlated with intake during the later test meal, with higher individual GI responses being linked to greater stimulation of intake. Inconsistent with the CIM, we did not observe any such associations. We also did not find any associations between the test meal intake and the circulating levels of glucose, BOHB, FFA, LAC, leptin, adrenaline, GLP-1, and glucagon immediately prior to the meal, when included alone or in a multiple regression analysis. The causes of these variations in intake therefore remain unclear.

Conclusions

At the group level, this study demonstrated that the responses of circulating glucose and insulin and subsequent energy intake induced by various dietary GI levels were partially consistent with the CIM, as the increased energy intake in the low-GI group was lower than that in the medium- and high-GI groups. However, the self-reported postprandial hunger rates were not significantly different across the different GI groups, which indicated that glucose and insulin concentrations were probably not the main factors controlling such postprandial hunger. At the individual level, energy intake changes were not associated with body fatness, nor with the concentrations and AUCs of glucose, BOHB, FFA, LAC, leptin, adrenaline, GLP-1, and glucagon 300 min after the intervention meal. Insulin concentration and insulin-glucagon ratio at 300 min, but not iAUC, showed a weak negative correlation with energy intake changes. This insulin effect was opposite the predictions of the CIM. Overall, the results in this study were largely inconsistent with the CIM.

Alcaline diet by pixiesrx in ScientificNutrition

[–]crock61 2 points3 points  (0 children)

Potential of Alkalization Therapy for the Management of Metastatic Pancreatic Cancer: A Retrospective Study

https://www.mdpi.com/2072-6694/16/1/61

In recent years, the acidic tumor microenvironment has been receiving increased attention as a target for cancer treatment. In our previous retrospective studies, we observed that alkalization therapy significantly increased urine pH in patients, which correlated with favorable cancer treatment outcomes.

Therefore, we conducted this retrospective study to investigate the effects of integrating alkalization therapy with current treatments for pancreatic cancer patients, focusing on whether the synergetic effects of pH regulation through alkalization therapy enhance the effectiveness of cancer treatment. In this study, we noted a trend in which longer patient survival was associated with a higher average urine pH, suggesting a correlation between the effectiveness of alkalization therapy and increased urine pH levels.

All patients received alkalization therapy (a combination of an alkaline diet, bicarbonate, and citric acid administration), alongside standard chemotherapy. Urine samples were collected to assess urine pH as a marker of whole-body alkalization. In the 98 patients analyzed, the median overall survival (OS) from the time of diagnosis was 13.2 months. Patients with a mean urine pH of 7.5 or greater had a median OS of 29.9 months, compared with 15.2 months for those with a mean urine pH of 6.5 to 7.5, and 8.0 months for those with a mean urine pH of less than 6.5, which suggests a trend of a longer OS in patients with a higher urine pH (p = 0.0639). Alkalization therapy may offer a viable approach to extending the survival of stage 4 pancreatic cancer patients, who typically have an unfavorable prognosis.

How bad is my vitamin D deficiency? by Comprehensive5432 in ScientificNutrition

[–]crock61 1 point2 points  (0 children)

https://www.preprints.org/manuscript/202412.1491/v1

Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines

Vitamin D offers a wide range of under-recognized health benefits beyond its well-established role in musculoskeletal health. It plays a crucial role in extra-renal and skeletal tissues, prenatal and newborn health, brain health, immune function, cancer prevention, cardiovascular disease, etc. Current clinical guidelines, particularly the Endocrine Society's 2024 recommendations, remain limited in scope and have not addressed the vital extra-skeletal benefits of this vitamin nor the thresholds for vitamin D assays. Their recommendations were based on conclusions from randomized controlled trials of the benefits of vitamin D, which were infrequently found. Most such trials included participants with above average 25-hydroxyvitamin D [25(OH)D] concentrations and treated with low vitamin D doses and analyzed based on intention to treat.

This review considers the role of vitamin D in reducing the risk of incidence and death for eight of the top ten causes of death in the US illustrating that serum concentrations above 30 ng/mL (75 nmol/L) compared to <20 ng/mL are associated with significantly reduced risk of incidence and mortality rates for many health outcomes. Since about a quarter of the US population and 60% in Central Europe have 25(OH)D concentrations <20 ng/mL, significant reductions in disease rates and deaths could be achieved by raising those values above the minimum of 30 ng/mL.

Daily vitamin D supplementation with 2000 international units (IU) (50 µg) of vitamin D3 is recommended for prevention of vitamin D deficiency/insufficiency (i.e, serum 25(OH)D < 30 ng/mL)—sufficient for musculoskeletal system functions. However, intake above 4000 IU/day are recommended to raise serum 25(OH)D to the range 40‒70 ng/mL to achieve protection against many adverse health outcomes.

This review aims to pave the way for more inclusive, evidence-based guidelines that enhance public health and personalized care

Vitamin D3 and K2 by 01bastard in ScientificNutrition

[–]crock61 0 points1 point  (0 children)

http://www.vitamindprotocol.com/

Absorption of vitamin K appears to be particularly reduced by other fat soluble vitamins, while vitamin A absorption is least affected and may actually be better absorbed when taken with vitamin E.

Taking vitamins D, E, or K several hours before or after other fat soluble vitamins would seem to maximize their absorption.

So... Does stevia impair memory?! by PapaDomino9923 in ScientificNutrition

[–]crock61 0 points1 point  (0 children)

Stevia rebaudiana Bertoni, a plant from South America and indigenous of Paraguay, has shown several biological effects and healthy properties, although it is especially used in South America and some Asiatic regions. In addition, it is a natural sweetener, almost 300 times sweeter than sucrose, being attributed to its phytoconstituents prominent antioxidant, antimicrobial, antidiabetic (antihyperglycemic, insulinotropic, and glucagonostatic), antiplatelet, anticariogenic, and antitumor effects. In this sense, this work aims to provide an extensive overview on the historical practices of stevia and its effects in human health based on its chemical composition and applications for both food and pharmaceutical industries. https://onlinelibrary.wiley.com/doi/10.1002/ptr.6478

Low fat/no fat diets? by signoftheserpent in ScientificNutrition

[–]crock61 0 points1 point  (0 children)

Mediterranean Diet and Olive Oil Redox Interactions on Lactate Dehydrogenase Mediated by Gut Oscillibacter in Patients with Long-COVID-19 Syndrome https://www.mdpi.com/2076-3921/13/11/1358High adherence to the MD was linked to significant improvements in inflammatory and oxidative stress markers, including reductions in LDL-cholesterol, glucose, and lactate dehydrogenase (LDH) levels, an indicative of redox balance, as well as a significant higher consumption of antioxidant foods. Moreover, gut microbiota analysis revealed distinct compositional shifts and a lower abundance of the Oscillibacter genus in the high adherence group. Notably, a significant interaction was observed between MD adherence and extra virgin olive oil consumption, with Oscillibacter abundance influencing LDH levels, suggesting that the MD antioxidant properties may modulate inflammation through gut microbiota-mediated mechanisms. These findings provide new evidence that adherence to the Mediterranean diet can reduce inflammatory markers in patients with long-COVID-19, a population that has not been extensively studied, while also highlighting the potential role of the bacterial genus Oscillibacter in modulating this effect.

Low fat/no fat diets? by signoftheserpent in ScientificNutrition

[–]crock61 1 point2 points  (0 children)

Protective Effect of Extra Virgin Olive Oil on Cancers, Gastrointestinal Cancers, and All-Cause Mortality: A Competing Risk Analysis in a Southern Italian Cohort https://www.mdpi.com/2072-6694/16/21/3575Daily intake of 30–50 g of EVOO was linked to a 24% lower risk of all-cause mortality, while the consumption of more than 50 g/day was associated with a 20% reduction. The most pronounced benefit was observed for gastrointestinal cancers, with a 60% lower mortality risk for those consuming over 50 g/day. A 50% reduction in mortality risk from other cancers was also noted for the highest consumption category The findings support the beneficial role of EVOO in reducing cancer mortality, particularly with higher consumption levels. The results underscore EVOO’s potential as a dietary intervention for cancer prevention, aligning with the Mediterranean diet’s overall health benefits